µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© WI}cXXUKm0
EaUO>S
Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© /YHAU5N/}
1¡¢Co-stimulators (or co-stimulating molecules) EEdU\9DH(
2¡¢NK-kB qEajT"?
3¡¢Immunoglobulin superfamily 83g$k
9lG.
4¡¢antigen-presenting cell (APC)
GW\66$|
5¡¢death domain ;<N%D=;}@
6¡¢CCR and CXCR Q7 @oAeNd
7¡¢Lectin (or mitogen) jN T+?2
8¡¢Clusters of differentiation, CD) P]%)c6Uh
9¡¢B7 family z[+Sb;
10¡¢Cytotoxic T lymphocyte, CTL) nR`)kORc
11¡¢IL-15 and IL-15 receptor (IL-15R) ^\C Fke=
12¡¢MHC restriction 5N(OW:M
13¡¢Affinity-chromatography fprP$MbI
14¡¢Cyctosprin A, CsA /_qW?LKG/
15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) V[2}
uZe"M(3r$
¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© |qz&d=>
1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 2KtK.2; 7
2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ +=K =B
3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ i!;9A6D
6KDm#7J
Èý¡¢ÎÊ´ðÌ⣨25·Ö£© 6_g:2=6S
1¡¢Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ eI,H
ѪҺ²¡Ñ§×¨Òµ£º mI'&!@WG
2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿